drugset / Trial / NCT02297802
A Single Patient IND for PD-0325901
Summary
The purpose of this study is to provide access for a single patient to PD-0325901 who was previously enrolled in a phase I clinical trial.
Timeline
- Start
- 2013-06
- Primary completion
- 2013-07
- Completion
- 2013-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mirdametinib | Small molecule | — | — |
Indications
No indication recorded.